Deferred Tax Assets, Valuation Allowance of ENANTA PHARMACEUTICALS INC from 30 Sep 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ENANTA PHARMACEUTICALS INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2010 to 30 Sep 2025.
  • ENANTA PHARMACEUTICALS INC Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2025 was $142,233,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ENANTA PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $142,233,000 +$14,989,000 +12% 30 Sep 2025 10-K 19 Nov 2025 2025 FY
Q3 2024 $127,244,000 +$12,124,000 +11% 30 Sep 2024 10-K 19 Nov 2025 2025 FY
Q3 2023 $115,120,000 +$47,394,000 +70% 30 Sep 2023 10-K 19 Nov 2025 2025 FY
Q3 2022 $67,726,000 +$38,428,000 +131% 30 Sep 2022 10-K 19 Nov 2025 2025 FY
Q3 2021 $29,298,000 +$11,039,000 +60% 30 Sep 2021 10-K 27 Nov 2024 2024 FY
Q3 2020 $18,259,000 +$18,259,000 30 Sep 2020 10-K 22 Nov 2023 2023 FY
Q3 2019 $0 30 Sep 2019 10-K 23 Nov 2022 2022 FY
Q3 2017 $0 $0 30 Sep 2017 10-K 29 Nov 2018 2018 FY
Q3 2016 $0 $0 30 Sep 2016 10-K 11 Dec 2017 2017 FY
Q3 2015 $0 $0 30 Sep 2015 10-K 09 Dec 2016 2016 FY
Q3 2014 $0 -$22,892,000 -100% 30 Sep 2014 10-K 11 Dec 2015 2015 FY
Q2 2014 $22,892,000 30 Jun 2014 10-Q 12 Aug 2014 2014 Q3
Q3 2013 $22,892,000 -$4,907,000 -18% 30 Sep 2013 10-K 11 Dec 2014 2014 FY
Q3 2012 $27,799,000 -$8,570,000 -24% 30 Sep 2012 10-K 11 Dec 2014 2014 FY
Q3 2011 $36,369,000 -$9,443,000 -21% 30 Sep 2011 10-K 11 Dec 2014 2014 FY
Q3 2010 $45,812,000 30 Sep 2010 10-K 18 Dec 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.